DropGenie raises $5M USD seed-plus round backed by BDC Capital
DropGenie raises $5 million USD backed by BDC to speed up biological discovery
AI Overview
DropGenie, a Montreal and Boston biotech startup, closed a $5 million USD seed-plus round after BDC Capital's Thrive Fund joined.
Why it matters
The round shows how a lab-automation startup positions miniaturized CRISPR screening as a data supplier for AI drug-discovery models, with named pharma partners and a launch planned for next year.